Weiliang Xia Selected Research

Prostaglandin H2 Thromboxane A2 Receptors

1/2019	Structural basis for ligand recognition of the human thromboxane A2 receptor.
9/2017	Thromboxane A2 receptor antagonist SQ29548 suppresses the LPS‑induced release of inflammatory cytokines in BV2 microglia cells via suppressing MAPK and NF‑κB signaling pathways.
10/2016	Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury.
1/2015	Thromboxane A2 receptor polymorphism in association with cerebral infarction and its regulation on platelet function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiliang Xia Research Topics

Disease

37	Neoplasms (Cancer) 01/2021 - 09/2007
12	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2007
11	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 09/2007
8	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2014
7	Ischemia 08/2021 - 03/2012
7	Breast Neoplasms (Breast Cancer) 01/2019 - 06/2008
6	Stroke (Strokes) 08/2021 - 02/2010
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2021 - 03/2012
5	Inflammation (Inflammations) 10/2020 - 02/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 10/2013
5	Brain Injuries (Brain Injury) 11/2017 - 02/2012
4	Brain Ischemia (Cerebral Ischemia) 08/2021 - 03/2012
4	Ischemic Stroke 08/2021 - 10/2016
4	Infarction (Infarctions) 11/2017 - 03/2012
3	Thrombosis (Thrombus) 09/2017 - 01/2015
3	Necrosis 09/2017 - 01/2011
3	Neuroinflammatory Diseases 01/2017 - 01/2013
3	Glioma (Gliomas) 01/2012 - 01/2011
2	Carcinogenesis 01/2019 - 10/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 02/2015
2	Cerebral Infarction 10/2016 - 01/2015
2	Hyperalgesia 01/2016 - 09/2014
2	Neuralgia (Stump Neuralgia) 01/2016 - 09/2014
2	Ototoxicity 02/2015 - 01/2015
2	Reperfusion Injury 10/2014 - 06/2014
2	Wounds and Injuries (Trauma) 09/2014 - 09/2007
2	Parkinson Disease (Parkinson's Disease) 02/2012 - 01/2011
2	Squamous Cell Carcinoma of Head and Neck 05/2010 - 08/2009
1	Adenocarcinoma of Lung 09/2021
1	Hypoxia (Hypoxemia) 08/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

12	1- (2,4- dichlorobenzyl)indazole- 3- carbohydrazide (adjudin)IBA 01/2019 - 01/2013
11	Small Interfering RNA (siRNA)IBA 09/2021 - 06/2008
11	Pharmaceutical PreparationsIBA 01/2019 - 09/2009
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2011
6	NAD (NADH)IBA 01/2018 - 01/2011
5	Sirtuin 3IBA 08/2021 - 09/2015
5	Hyaluronic Acid (Hyaluronan)IBA 12/2011 - 06/2008
4	Prostaglandin H2 Thromboxane A2 ReceptorsIBA 01/2019 - 01/2015
4	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 06/2008
4	Sirtuin 2IBA 10/2013 - 01/2011
3	Transcription Factors (Transcription Factor)IBA 06/2022 - 06/2008
3	Messenger RNA (mRNA)IBA 09/2021 - 10/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021 - 01/2013
3	Oxygen (Dioxygen)IBA 08/2021 - 04/2016
3	Glucose (Dextrose)FDA LinkGeneric 08/2021 - 04/2016
3	CateninsIBA 04/2020 - 01/2018
3	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 09/2019 - 01/2017
3	Biological ProductsIBA 01/2019 - 01/2011
3	CytokinesIBA 10/2016 - 02/2010
3	Silicon Dioxide (Silica)FDA LinkGeneric 12/2014 - 01/2012
3	Caspase 3 (Caspase-3)IBA 01/2012 - 09/2007
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2020 - 04/2020
2	MicroRNAs (MicroRNA)IBA 09/2019 - 01/2019
2	Thromboxane A2 (A2, Thromboxane)IBA 01/2019 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 06/2008
2	SirtuinsIBA 01/2019 - 02/2012
2	LigandsIBA 01/2018 - 05/2010
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018 - 01/2017
2	AndrogensIBA 01/2018 - 09/2007
2	Therapeutic UsesIBA 11/2017 - 01/2011
2	LipopolysaccharidesIBA 01/2017 - 01/2013
2	AZD4547IBA 01/2017 - 03/2016
2	Histone Deacetylases (Histone Deacetylase)IBA 04/2016 - 01/2009
2	Gentamicins (Gentamicin)FDA LinkGeneric 02/2015 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2015 - 05/2010
2	Protein Kinases (Protein Kinase)IBA 01/2015 - 09/2009
2	multidrug resistance-associated protein 1IBA 01/2014 - 04/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014 - 04/2013
2	Adenosine Triphosphate (ATP)IBA 01/2014 - 02/2013
2	Male Contraceptive Agents (Male Contraceptives)IBA 01/2014 - 02/2013
2	enhanced green fluorescent proteinIBA 01/2013 - 12/2011
2	CalciumIBA 02/2012 - 01/2011
2	Sirtuin 1IBA 02/2012 - 01/2009
1	Androgen Receptors (Androgen Receptor)IBA 06/2022
1	B7-H1 AntigenIBA 09/2021
1	AntibodiesIBA 09/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2021
1	Glial Fibrillary Acidic ProteinIBA 08/2021
1	p21-Activated KinasesIBA 10/2020
1	ChloridesIBA 10/2020
1	ElectrolytesIBA 10/2020
1	Adenosine Monophosphate (AMP)IBA 04/2020
1	Circular RNAIBA 01/2020
1	LuciferasesIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	AntagomirsIBA 01/2019
1	Arachidonic Acid (Vitamin F)IBA 01/2019
1	XAV939IBA 01/2018

Therapy/Procedure

14	Therapeutics 08/2021 - 08/2009
7	Castration 06/2022 - 01/2018
4	Synchrotrons 01/2015 - 01/2012
3	Precision Medicine 01/2020 - 10/2012
3	Liver Transplantation 01/2017 - 02/2015
2	Immunotherapy 01/2022 - 09/2021
2	Aftercare (After-Treatment) 01/2019 - 09/2014
2	Ligation 01/2016 - 09/2014
2	Drug Therapy (Chemotherapy) 09/2009 - 06/2008